Physician profile
Robert M Risica
NPI 1205881984
$2,596.63
in general payments reported to CMS, 2019-2025
17 companies · $736 in 2025
The $736 reported for 2025 was more than what 80% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.25 · 2023: $743 · 2024: $1,036 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,515.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $515.88 | 2023-2025 | Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $514.59 | 2023-2025 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $349.32 | 2023-2025 | Fasenra, Airsupra |
| Pfizer INC. | $298.07 | 2023-2024 | |
| Optinose US, INC. | $254.09 | 2023-2025 | |
| Genzyme Corporation | $196.80 | 2024-2025 | |
| Abbvie INC. | $80.08 | 2024-2025 | |
| Ars Pharmaceuticals Operations, INC. | $66.95 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $54.75 | 2023-2025 | Ryaltris |
| Paratek Pharmaceuticals, INC. | $52.00 | 2025 | Xhance |
| Stryker Corporation | $49.79 | 2019 | |
| Watermark Medical, INC. | $36.14 | 2024 | |
| Intersect Ent, INC. | $31.46 | 2019 | |
| Genentech USA, INC. | $30.98 | 2025 | Xolair |
| Amgen INC. | $28.34 | 2025 | Tavneos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.43 | 2025 | |
| Kaleo, INC. | $14.96 | 2023 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Risica listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.